EGFR and lung cancer: We proposed that higher angiogenic ability observed in lung cancer cells with exon 19 deletion was through increased phosphorylation of EGFR and downstream pathways, thus the growth of lung tumors with exon 19 deletion may rely more on angiogenesis.